NEW YORK, Dec. 11 - AxCell Biosciences said Tuesday it had agreed to run a pilot program for Pluvita to determine protein interactions based on signal transduction research.

Axcell said it would identify full-length peptides that bind to a compound Pluvita has earmarked for the research program. 

Financial and other terms of the agreement were not disclosed. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more